Europe Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Europe Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Europe Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and the Rest of Europe) Industry Trends and Forecast to 2030

Market Definition:

Thyroid cancer is a type of cancer that starts in the thyroid gland. Cancer starts when cells begin to grow out of control. The thyroid gland makes hormones that help regulate your metabolism, heart rate, blood pressure, and body temperature. The thyroid gland is in the front part of the neck, below the thyroid cartilage (Adam's apple). In most people, the thyroid cannot be seen or felt. It is shaped such as a butterfly, with two lobes — the right lobe and the left lobe — joined by a narrow piece of the gland called the isthmus.

Symptoms include difficulty breathing or swallowing, loss of voice (hoarseness), and swollen lymph nodes in your neck. These symptoms often do not appear until the cancer is advanced. Treatments vary but may include surgery, chemotherapy, radiation therapy, targeted drug therapy, and immunotherapy.

Market Segmentation:

The Europe thyroid cancer diagnostics market is categorized into seven notable segments based on product type, test type, cancer type, stages, age group, end user, and distribution channel.
• On the basis of product type, the Europe thyroid cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the Europe thyroid cancer diagnostics market is segmented into imaging test, blood test, biopsy, and others
• On the basis of cancer type, the Europe thyroid cancer diagnostics market is segmented into papillary carcinoma, follicular carcinoma, others
• On the basis of stages, the Europe thyroid cancer diagnostics market is segmented into stage I, stage II, stage III, stage IV
• On the basis of age group, the Europe thyroid cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, below 21
• On the basis of end users, the Europe thyroid cancer diagnostics market is segmented into hospital, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, others
• On the basis of distribution channel, the Europe thyroid cancer diagnostics market is segmented into direct tender and retail sales

Market Players

Some of the major players operating in the Europe thyroid cancer diagnostics market are:
• FUJIFILM Holdings Corporation
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• Illumina
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Abbott
• General Electric Company
• BD
• QIAGEN
• DIASORIN S.P.A.
• Merck KGaA
• Hologic
• Myriad Genetics Inc.
• BIOMERIEUX
• FONAR Corp.
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• SternMed GmbH.